Catalent Inc (CTLT) Holdings Boosted by Jane Street Group LLC
Jane Street Group LLC raised its stake in shares of Catalent Inc (NYSE:CTLT) by 137.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 16,397 shares of the company’s stock after purchasing an additional 9,490 shares during the period. Jane Street Group LLC’s holdings in Catalent were worth $655,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Acrospire Investment Management LLC raised its stake in Catalent by 72.2% during the second quarter. Acrospire Investment Management LLC now owns 3,100 shares of the company’s stock worth $109,000 after purchasing an additional 1,300 shares during the period. Quantbot Technologies LP raised its stake in Catalent by 110.7% during the second quarter. Quantbot Technologies LP now owns 3,434 shares of the company’s stock worth $120,000 after purchasing an additional 1,804 shares during the period. Fortaleza Asset Management Inc. purchased a new position in Catalent during the third quarter worth about $164,000. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in Catalent by 12.5% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 5,043 shares of the company’s stock worth $177,000 after purchasing an additional 559 shares during the period. Finally, Advisor Group Inc. raised its stake in Catalent by 1.3% during the second quarter. Advisor Group Inc. now owns 5,185 shares of the company’s stock worth $180,000 after purchasing an additional 65 shares during the period. 99.49% of the stock is currently owned by institutional investors and hedge funds.
CTLT has been the topic of a number of analyst reports. Bank of America reaffirmed a “buy” rating and set a $40.00 target price (up from $38.00) on shares of Catalent in a research note on Tuesday, August 29th. BidaskClub upgraded shares of Catalent from a “hold” rating to a “buy” rating in a research report on Friday, September 8th. ValuEngine upgraded shares of Catalent from a “hold” rating to a “buy” rating in a research report on Thursday, September 7th. J P Morgan Chase & Co reiterated a “buy” rating and set a $40.00 price target on shares of Catalent in a research report on Tuesday, August 29th. Finally, Piper Jaffray Companies reiterated a “buy” rating and set a $45.00 price target on shares of Catalent in a research report on Tuesday, August 29th. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Catalent currently has an average rating of “Buy” and a consensus target price of $44.44.
Catalent Inc (CTLT) opened at $41.12 on Friday. Catalent Inc has a 12 month low of $25.51 and a 12 month high of $43.39. The company has a quick ratio of 2.49, a current ratio of 2.91 and a debt-to-equity ratio of 2.01. The stock has a market cap of $5,322.35, a P/E ratio of 28.01, a P/E/G ratio of 2.57 and a beta of 1.41.
Catalent (NYSE:CTLT) last issued its quarterly earnings results on Monday, November 6th. The company reported $0.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.20 by $0.01. Catalent had a net margin of 5.01% and a return on equity of 23.97%. The company had revenue of $543.90 million during the quarter, compared to the consensus estimate of $490.75 million. During the same quarter in the previous year, the firm earned $0.16 earnings per share. The firm’s quarterly revenue was up 23.0% on a year-over-year basis. equities research analysts forecast that Catalent Inc will post 1.46 EPS for the current fiscal year.
In other news, insider John R. Chiminski sold 181,458 shares of the business’s stock in a transaction that occurred on Tuesday, December 12th. The shares were sold at an average price of $39.62, for a total transaction of $7,189,365.96. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Uwe Roehrhoff acquired 7,500 shares of Catalent stock in a transaction dated Tuesday, November 21st. The shares were bought at an average price of $39.22 per share, with a total value of $294,150.00. The disclosure for this purchase can be found here. 1.70% of the stock is owned by insiders.
Catalent, Inc provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels.
Want to see what other hedge funds are holding CTLT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Catalent Inc (NYSE:CTLT).
Receive News & Ratings for Catalent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catalent and related companies with MarketBeat.com's FREE daily email newsletter.